. yO
MAY - 1 2009 Ovi se 5
TRONTER 1S : AutoLITT™ System
MeDIeas : Combined Premarket Notification (K081509)
CINE Premartet Notification (KO81I09)
Section 5: 510(k) Summary
a. Device Information:
Sponsor: - | Monteris Medical, Inc.
100 — 78 Innovation Drive
Winnipeg, Manitoba
CANADA R3T 6C2
Tel: 204-272-2220
Fax: 204-272-2219 .
www. inonteris.com
Correspondent Contact Craig Coombs
‘Information: Coombs Medical Device Consulting
1193 Sherman Street
Alameda, CA 94501
Tel: 510-337-0140 ‘
Fax: 510-337-0416
Device Common Name: Magnetic Resonance Image Guided Laser
: Thermal Therapy System
‘ Device Classification & Class II
Code: GEX ,
Device Classification 21CFR878.4810
. Name: Laser surgical instrument for use in general
: and plastic surgery and in dermatolog
Device Proprietary Monteris Medical AutoLITT™ System
Name: | :
Predicate Device Information:
_ | Predicate Devices: Therapy System Surgical Laser System NaviVision
PY SY & Accessories
Manufacturers:
Magnetic Resonance , .
System
Notification # :
Classification: :
Predicate Device . :
Code:
b. Date Summary Prepared :
. 28 April 2009 :

c
. > MONTERIS AutoLiTT™ System
a ____Lombined Premarket Notification (K08)509)
c. Description of Device
The Monteris AutoLITT™ System is a combination of three major components:
Monteris AutoLITT™ Laser Probe
Monteris AutoLITT™ Probe Driver
Monteris AutoLITT™ VizApp Software : /
: d. Intended Use
The Monteris Medical AutoLITT System is indicated for use to necrotize
or coagulate soft tissue through interstitial irradiation or thermal therapy
: in medicine and surgery in the discipline of neurosurgery with 1064 nm
lasers.
The Monteris Medical AutoLITT System is intended for planning and
monitoring thermal therapies under MRI visualization. It provides MRIbased trajectory planning assistance for the stereotaxic placement of MRI
compatible (conditional) AutoLITT Laser Delivery Probe. It also provides
real-time thermographic analysis of selected MR images. /
When interpreted by a trained physician, this System provides information
that may be useful in the determination or assessment of thermal therapy.
Patient management decisions should not be made solely on the basis of
the AutoLITT analysis.
e, Comparison to Predicate Device ‘
The Monteris Medical AutoLITT™ System is substantially equivalent to the above
described predicate devices in intended use, technology, design and physician use.
f. Summary of Supporting Data .
Biocompatibility data demonstrates that the Laser Probe is in compliance with ISO
10993, .
Bench testing has demonstrated that the System is in compliance with the medical
community’s expectations and the product labeling.
Animal testing demonstrated that the System, can be used to coagulate brain tissue under *
MRI guidance.

2 ¢ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
“re woe :
Food and Drug Administration
MAY ~ 1.2009 2200 Corporate ouevard
Monteris Medical
% Coombs Medical Device Consulting, Inc.
Mr. Craig Coombs
President ,
1193 Sherman Street
Alameda, California 94501
Re: K081509
Trade/Device Name: Monteris Medical AutoLITT™ System
Regulation Number: 21 CFR 878.4810 :
Regulation Name: Laser surgical instrument for use in general and plastic surgery
and in dermatology .
Regulatory Class: II
Product Code: GEX
Dated: March 6, 2009
Received: March 9, 2009
Dear Mr. Coombs:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
- + devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration. :
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean .
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. Craig Coombs
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Center for Devices and Radiological Health’s (CDRH’s) Office of Compliance at
(240) 276-0115. Also, please note the regulation entitled, “Misbranding by reference to
premarket notification” (21CFR Part 807.97). For questions regarding the reporting of adverse
events under the MDR regulation (21 CFR Part 803), please contact the CDRH/Office of
Surveillance and Biometrics/Division of Postmarket Surveillancé at (240) 276-3464. For more
information regarding the reporting of adverse events, please go to
http://www.fda.gov/edrh/mdr/.
You may obtain other general information on your responsibilities under the Act from the
' Division of Small Manufacturers, International and Consumer Assistance at its toll-free number
(800) 638-2041 or (240) 276-3150 or at its Internet address
http://www.fda gov/cdrh/industry/support/index. html.
allyl. al, —
Mark N. Melkerson
Division of General, Restorative :
and Neurological Devices .
Office of Device Evaluation
Center for Devices and
: Radiological Health
Enclosure

Indications for Use
510(k) Number (if known): K0Q81509 ,
Device Name: Monteris Medical AutoLITT™ System
Indications For Use: ,
. The Monteris Medical AutolITT System is indicated for use to
necrotize or coagulate soft tissue through interstitial irradiation or
thermal therapy in medicine and surgery in the discipline of
neurosurgery with 1064 nm lasers. :
The Monteris Medical AutoLITT System is intended for planning
. _and monitoring thermal therapies under MRI visualization. It :
provides MRI-based trajectory planning assistance for the
stereotaxic placement of MRI compatible (conditional) AutoLITT
Laser Delivery Probe. It also provides real-time thermographic
analysis of selected MRI images.
When interpreted by a trained physician, this System provides
information that may be useful in the determination or assessment
of thermal therapy. Patient management decisions should not be
made solely on the basis of the AutoLITT analysis.
Prescription Use Xx AND/OR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) , (21 CFR 807 Subpart C)
’ (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF
NEEDED) .
a
Concurrence of CDRH, Office of Device Evaluation (ODE) ,
(Division Sign-Off) Page 1 of 1
Division of General, Restorative,
and Neurological Devices
510(k) Number_ KO 31504. |

